GOLM1, CD24, PSCA, and the gene fusion TMPRSS2-ERG were selected as overexpressed mRNAs in prostate cancer, whereas ANXA3 and SLC45A3 were selected as underexpressed mRNAs in prostate cancer for evaluation. Here, GOLM1 is linked to Familial prostate cancer.